Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522

Urologia Internationalis

Volumn 84, Issue 3, 2010, Pages 362-368

  Sato, Nodoka ^a   Mizutani, Yoichi ^a   Li, Yong Nan ^a   Fujiwara, Jun ^a   Ishida, Hirokazu ^a   Toiyama, Daisuke ^a   Abe, Koichi ^a   Hayashi, Issei ^a   Nakanishi, Hiroyuki ^a   Kawauchi, Akihiro ^a   Miki, Tsuneharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cyclooxygenase 2; Fas; Immunotherapy; Kidney cancer; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CH 11; CISPLATIN; CYCLOOXYGENASE 2; DOXORUBICIN; FAS ANTIGEN; FLUOROURACIL; TILMACOXIB; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZENESULFONATES; CARCINOMA, RENAL CELL; CYCLOOXYGENASE 2 INHIBITORS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KIDNEY NEOPLASMS; OXAZOLES; TUMOR CELLS, CULTURED;

EID: 77951102826     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000288243     Document Type: Article

References (26)

1. Bex A, Haanen JB, Vyth-Dreese FA, Horenblas S, de Gast GC: Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis. Urol Int 2008; 80: 367-371.
2. Taketo MM: Cyclooxygenase-2 inhibitors in tumorigenesis (part II). J Natl Cancer Inst 1998; 90: 1609-1620.
3. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K: Cyclooxygenase- expression in human esophageal carcinoma. Cancer Res 1999; 59: 198-204.
4. Yoshimura R, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Chargui J, Yoshimura N, Hla T, Wada S: Expression of cyclooxygenase-in prostate carcinoma. Cancer 2000; 89: 589-596.
5. Shirahama T, Arima J, Akiba S, Sakakura C: Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer 2001; 92: 188-193.
6. Gurocak S, Sozen S, Erdem O, Ozkan S, Kordan Y, Alkibay T, Akyol G, Bozkirli I: Relation between cyclooxygenase-2 expression and clinicopathologic parameters with patient prognosis in transitional cell carcinoma of the bladder. Urol Int 2006; 76: 51-56.
7. Chen Q, Shinohara N, Abe T, Watanabe T, Nonomura K, Koyanagi T: Significance of COX-2 expression in human renal cell carcinoma cell lines. Int J Cancer 2004; 108: 825-832. (Pubitemid 38112609)
8. Hashimoto Y, Kondo Y, Kimura G, Matsuzawa I, Sato S, Ishizaki M, Imura N, Akimoto M, Hara S: Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma. Histopathology 2004; 44: 353-359.
9. Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T: Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol 2005; 23: 448-454.
10. Mizutani Y, Matsubara H, Yamamoto K, Nan Li Y, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T: Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma. Cancer 2004; 101: 1794-1802. (Pubitemid 39314742)
11. Sievers E, Dreimuller P, Haferkamp A, Schmidt-Wolf IG, Buchler MW, Schmidt J, Marten A: Characterization of primary renal carcinoma cultures. Urol Int 2007; 79: 235-243.
12. Baba M, Hirai S, Kawakami S, Kishida T, Sakai N, Kaneko S, Yao M, Shuin T, Kubota Y, Hosaka M, Ohno S: Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth. Oncogene 2001; 20: 2727-2736.
13. Matsushita M, Masaki M, Yagi Y, Tanaka T, Wakitani K: Pharmacological profile of JTE- 522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm Res 1997; 46: 461-466.
14. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601.
15. Murai N, Ueba T, Takahashi JA, Yang HQ, Kikuchi H, Hiai H, Hatanaka M, Fukumoto M: Apoptosis of human glioma cells in vitro and in vivo induced by a neutralizing antibody against human basic fibroblast growth factor. J Neurosurg 1996; 85: 1072-1077.
16. Berenbaum MC: Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol 1977; 28: 1-18.
17. Mizutani Y, Nakanishi H, Yoshida O, Fukushima M, Bonavida B, Miki T: Potentiation of the sensitivity of renal cell carcinoma cells to trail-mediated apoptosis by subtoxic concentrations of 5-fluorouracil. Eur J Cancer 2002; 38: 167-176.
18. Kinoshita T, Takahashi Y, Sakashita T, Inoue H, Tanabe T, Yoshimoto T: Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases and 2 in human colon carcinoma cells. Biochim Biophys Acta 1999; 1438: 120-130.
19. Li M, Wu X, Xu XC: Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin Cancer Res 2001; 7: 1010-1016. (Pubitemid 32708740)
20. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B: Role of BAX in the apoptotic response to anticancer agents. Science 2000; 290: 989-992.
21. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
22. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151: 621-627.
23. Sato T, Irie S, Kitada S, Reed JC: FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995; 268: 411-415.
24. Liu XH, Yao S, Kirschenbaum A, Levine AC: NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 1998; 58: 4245-4249.
25. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-716.
26. Schmidt NO, Westphal M, Hagel C, Ergun S, Stavrou D, Rosen EM, Lamszus K: Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 1999; 84: 10-18.